Search Results - "Bellomarino, Vittorio"
-
1
Ponatinib alone or with chemo-immunotherapy in heavily pre-treated Philadelphia-like acute lymphoblastic leukemia: a CAMPUS ALL real-life study
Published in Haematologica (Roma) (01-08-2024)“…Not available.Not available…”
Get full text
Journal Article -
2
Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?
Published in Frontiers in oncology (14-03-2023)“…Minimal/measurable residual disease (MRD) monitoring is progressively changing the management of hematologic malignancies. The possibility of detecting the…”
Get full text
Journal Article -
3
PB1711: DROPLET DIGITAL PCR DETECTION OF THE T315I BCR::ABL1 KD MUTATION IN ADULT PH‐POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
4
-
5
-
6
Dissecting Ph-like ALL: The Role of Genomic Lesion and Minimal Residual Disease in Refining Outcome
Published in Blood (15-11-2022)Get full text
Journal Article -
7
Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic Leukemia
Published in Cancers (06-01-2023)“…Minimal/measurable residual disease (MRD) evaluation has resulted in a fundamental instrument to guide patient management in acute lymphoblastic leukemia…”
Get full text
Journal Article -
8
-
9
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia
Published in The Journal of molecular diagnostics : JMD (01-08-2022)“…Digital droplet PCR (ddPCR) is an implementation of conventional PCR, with the potential of overcoming some limitations of real-time quantitative PCR (RQ-PCR)…”
Get full text
Journal Article -
10
Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases
Published in Hematological oncology (01-02-2023)“…Circulating tumor DNA (ctDNA) has become the most investigated analyte in blood. It is shed from the tumor into the circulation and represents a subset of the…”
Get full text
Journal Article